Geron (GERN)

Add to Watchlists Create an Alert
2.525 -0.07  -2.51% NASDAQ Jul 23, 5:00PM BATS Real time Currency in USD
View Full Chart
GERN Price Chart
View All Events

GERN Events

Date Type Description
05/20/2014 Misc Annual General Meeting for Geron Corp
05/01/2014 16:30 EDT Misc Q1 2014 Geron Earnings Conference Call
05/01/2014 Earnings Q1 2014 Geron Earnings Result. Estimate: -0.06.
03/12/2014 16:30 EDT Misc Q4 2013 Geron Corporation Earnings Conference Call
03/12/2014 Earnings Q4 2013 Geron Corporation Earnings Results. Estimate: -0.06.
11/07/2013 16:30 EDT Misc Q3 2013 Geron Earnings Conference Call
11/07/2013 Earnings Q3 2013 Geron Earnings Results. Estimate: -0.06.
08/08/2013 13:30 PDT Misc Q2 2013 Geron Earnings Conference Call
08/08/2013 Earnings Second Quarter 2013 Financial Results. Estimate: -0.07.
View All Performance Charts

GERN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Geron is up 89.53% over the last year vs S&P 500 Total Return up 19.65%, BioTime down 31.85%, and Actelion up 93.78%.

Get Quote for
Advertisement

Portfolio Strategies Featuring GERN

Did Geron make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

GERN Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.geron.com
  • IR Website: http://ir.geron.com/phoenix.zhtml?c=67323&p=irol-irhome
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: March 31, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Geron Corp is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic products for oncology such as telomerase inhibitor, imetelstat and in hematologic myeloid malignancies, among others.

GERN Excel Add-In Codes

  • Name: =YCI("GERN","name")
  • Description: =YCI("GERN","description")
  • Sector: =YCI("GERN","sector")
  • Industry: =YCI("GERN","industry")
  • Est. Current Fiscal Year End: =YCI("GERN","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.